Managing Immunotherapy Toxicities
Learning Objectives
1.) Review mechanism of PD-1/PD-L1 therapies in cancer treatment
2.) Describe common and serious adverse events of PD-1/PD-L1 therapies
3.) Explain the role of steroids and other management strategies in PD-1/PD-L1 therapy toxicity
4.) Summarize treatment considerations with prolonged immunosuppression
Available Credit
- 1.00 ACPE - Pharmacist
- 1.00 ACPE - Pharmacy Technician
- 1.00 AMA PRA Category 1 Credit(s)™
- 1.00 ANCC
- 1.00 Attendance
- 1.00 JA Credit - AH
- 1.00 Approved for AMA PRA Category 1 Credit(s)™